{
  "id": "5e38ec8f026ce631",
  "title": "Sol - Gel Provides Update Following Unblinding of Phase 1b Study of SGT - 210 in Darier Disease",
  "description": "20251217T130000Z",
  "content": "",
  "source": "manilatimes.net",
  "source_url": "https://www.manilatimes.net/2025/12/17/tmt-newswire/globenewswire/sol-gel-provides-update-following-unblinding-of-phase-1b-study-of-sgt-210-in-darier-disease/2245187",
  "published_at": "20251217T130000Z",
  "fetched_at": "2025-12-18T00:22:47.263985+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "Philippines",
  "raw_data": {
    "url": "https://www.manilatimes.net/2025/12/17/tmt-newswire/globenewswire/sol-gel-provides-update-following-unblinding-of-phase-1b-study-of-sgt-210-in-darier-disease/2245187",
    "url_mobile": "https://www.manilatimes.net/2025/12/17/tmt-newswire/globenewswire/sol-gel-provides-update-following-unblinding-of-phase-1b-study-of-sgt-210-in-darier-disease/2245187/amp",
    "title": "Sol - Gel Provides Update Following Unblinding of Phase 1b Study of SGT - 210 in Darier Disease",
    "seendate": "20251217T130000Z",
    "socialimage": "https://www.manilatimes.net/manilatimes/uploads/images/2025/12/17/871168.jpg",
    "domain": "manilatimes.net",
    "language": "English",
    "sourcecountry": "Philippines"
  }
}